1st Circuit Dupixent news shows skin cancer cases across Maine, Massachusetts, New Hampshire, Rhode Island, and Puerto Rico. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a […]
Dupixent Claims Update
11 posts
Stay informed with every Dupixent Update covering new lawsuits, cancer claims, and breaking legal developments. This section provides continuous coverage of emerging Dupixent MDL updates, major rulings, and settlement discussions across federal and state courts.
For FAQs about the ongoing cancer litigation, please see our Dupixent lawyers homepage.
Dupixent MDL Update
Our Dupixent MDL update tracks the evolving multidistrict litigation involving Dupixent and its alleged link to certain cancers.
Readers can follow updates from case filings, judicial conferences, and scientific reports influencing current claims.
Each post focuses on court schedules, judge orders, and law firm announcements shaping national Dupixent litigation strategy.
Follow this link for our complete update on Dupixent Multi-District Litigation (MDL).
Dupixent Settlement Update
Our Dupixent settlement update reports highlight progress in negotiations and compensation trends for affected patients.
These updates explain settlement structures, expected payout ranges, and claim eligibility details.
Victims and attorneys can stay current on active mediation sessions and finalized agreements within Dupixent-related cancer claims.
Dupixent Cancer Update
The Dupixent Cancer Update section provides verified scientific and medical news connecting Dupixent use to potential cancer risks.
Readers will find research summaries, case studies, and expert testimony related to Cutaneous T-Cell Lymphoma, Mycosis Fungoides, and Sézary Syndrome.
This section aims to clarify new findings and court discussions about Dupixent’s biological mechanisms and long-term safety data.
2nd Circuit Dupixent news shows skin cancer cases across New York, Connecticut, and Vermont. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 2nd Circuit Dupixent settlement. […]
3rd Circuit Dupixent news shows skin cancer cases across New Jersey, Pennsylvania, and Delaware. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 3rd Circuit Dupixent settlement. […]
4th Circuit Dupixent news shows skin cancer cases across North Carolina, South Carolina, Maryland, Virginia, and West Virginia. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a […]
5th Circuit Dupixent news shows skin cancer cases across Louisiana, Mississippi, and Texas. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 5th Circuit Dupixent settlement. Louisiana […]
6th Circuit Dupixent news shows skin cancer cases across Kentucky, Michigan, Ohio, and Tennessee. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 6th Circuit Dupixent settlement. […]
7th Circuit Dupixent news shows skin cancer cases across Illinois, Indiana, and Wisconsin. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 7th Circuit Dupixent settlement. Illinois […]
8th Circuit Dupixent news shows skin cancer cases across Arkansas, Iowa, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming […]
9th Circuit Dupixent news shows skin cancer cases across California, Nevada, Arizona, Oregon, Washington, Idaho, and Montana. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 9th […]
10th Circuit Dupixent news shows skin cancer cases across Colorado, Kansas, New Mexico, Oklahoma, Utah, and Wyoming. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming a 10th […]
11th Circuit Dupixent news shows skin cancer cases across Alabama, Florida, and Georgia. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims. To learn more, please see our information on claiming an 11th Circuit Dupixent settlement. Alabama […]